News Medical on MSN1d
Grifols receives grant for early Parkinson's disease biomarker discovery
Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
New Atlas2d
Michael J. Fox funds early warning Parkinson's biomarker initiative
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
The Corner1d
Michael J. Fox Foundation donates Grifols $21 million to research new diagnostic tools for Parkinson’s disease
The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...
PharmaTimes3d
Grifols pioneers high-tech analysis of plasma bank to detect Parkinson’s disease
Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based ...
pharmaphorum3d
Could Spain’s Grifols be heading for de-listing?
At the same time, Grifols has formed a strategic alliance with Haier in the market for plasma products, particularly albumin, and diagnostics. It has been involved in a series of acquisitions in ...
Pharmaceutical Technology18d
Immune globulin (human) by Grifols for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Immune globulin (human) is under clinical development by Grifols and currently in Phase II for Coronavirus Disease 2019 (COVID-19).
TMCnet3d
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease
The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...